Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Alkermes AND trip-2
Show Display Options
Rank Status Study
1 Completed
Has Results
ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Placebo;   Drug: TrIP-2D;   Drug: TrIP-2SS;   Drug: TrIP-2SS + Foradil
2 Completed Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: trospium chloride inhalation powder (TrIP);   Drug: Placebo

Indicates status has not been verified in more than two years